青光眼治疗市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00018828
  • Category : Pharmaceuticals
  • Status : Data Released
  • No. of Pages : 150
Buy Now

青光眼治疗市场规模预计将从 2023 年的 62.4 亿美元增至 2031 年的 80.2 亿美元。预计 2023-2031 年该市场的复合年增长率为 3.2%。新型药物输送方法和联合疗法的开发可能仍然是青光眼治疗市场的主要趋势。

青光眼治疗市场分析< /h3>

青光眼是一组以神经组织逐渐丧失为特征的眼部疾病,如果不及时治疗,最终会导致视力丧失。前列腺素类似物是通过促进眼睛更好地排水而非常有效地降低眼压的药物之一。青光眼患病率的飙升和不断增加的产品上市预计将有利于青光眼治疗市场的增长。

青光眼治疗市场概述

全球人口老龄化导致青光眼发病率不断上升,为青光眼治疗市场的增长创造了重大机遇。由于老龄化人口对该疾病的敏感性更高,对创新疗法和管理策略的需求正在上升。此外,定期眼科检查对于早期发现和治疗青光眼的重要性增加了患者的参与度和对先进治疗的需求。随着医疗保健系统满足人口老龄化的需求,对青光眼研究、开发和获得护理的投资预计将在未来几年推动市场增长。

青光眼治疗市场驱动因素和机遇

增加青光眼疾病以利于市场

根据青光眼研究基金会的数据,到 2022 年,约 80全球有数百万人患有青光眼。 2010年,全世界有近840万人因原发性开角型青光眼而丧失视力。据青光眼研究基金会称,到 2040 年,这一数字预计将增加到 2200 万。这预计将增加未来一段时间内对青光眼治疗的需求。全球人口中青光眼发病率的上升是全球青光眼治疗市场的主要驱动力。

战略见解

发展可穿戴技术的发展——青光眼治疗定制的机会

青光眼是导致失明的主要原因,早期发现和治疗至关重要。可穿戴青光眼诊断和治疗已成为潜在的解决方案。传统的诊断技术可提供可靠的眼压数据,但新兴的隐形眼镜(例如 Sensimed Triggerfish)可提供连续的 IOP 跟踪。对于治疗而言,药物洗脱隐形眼镜正在成为一种潜在的解决方案。治疗诊断平台将诊断和治疗功能结合到一个设备中,提供实时监测和个性化药物剂量。

青光眼治疗市场报告细分分析

有助于得出青光眼治疗市场分析的关键部分是药物类别、适应症和分销渠道。

  • 基于药物类别
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which type segment dominates the glaucoma therapeutics market?

The glaucoma therapeutics market by drug class, is divided into beta blockers, alpha-adrenergic agonists, prostaglandin analogs, carbonic anhydrase inhibitors, combination drugs, and others. The prostaglandin analogs segment held a larger market share in 2023.

What was the estimated glaucoma therapeutics market size in 2023?

The glaucoma therapeutics informatics was valued at US$ 6.24 billion in 2023.

What factors drive the glaucoma therapeutics market?

Key factors driving the glaucoma therapeutics informatics growth are the surging prevalence of glaucoma and increasing product launches.

Who are the major players in the glaucoma therapeutics market?

The glaucoma therapeutics market majorly consists of the players, including Inoteck Pharmaceuticals; Merck & Co., Inc.; Novartis AG; Pfizer Inc.; Santen Pharmaceutical Co., Ltd.; Teva Pharmaceutical Industries Ltd; Takeda Pharmaceutical Company; AstraZeneca PLC; AERIE Pharmaceuticals, Inc.; and Cipla Inc.

What are glaucoma therapeutics?

Glaucoma is a group of eye disorders characterized by the gradual loss of nerve tissue that would eventually lead to vision loss if left untreated. Prostaglandin analogs are among the drugs that are highly effective in reducing eye pressure by promoting better drainage from the eye.

What are the growth estimates for the glaucoma therapeutics market till 2031?

The glaucoma therapeutics market is expected to be valued at US$ 8.02 billion in 2031.

The List of Companies - Glaucoma Therapeutics Market

  1. Fera Pharmaceuticals
  2. GlaxoSmithKline plc
  3. Bristol Myers Squibb
  4. Eli Lilly and Company
  5. Amgen
  6. MannKind Corporation
  7. Sangamo Therapeutics
  8. SciClone Pharmaceuticals, Inc.
  9. Critical Therapeutics, Inc.
  10. Takeda Pharmaceutical Company   

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports